Pharmaceuticals, Biotechnology, Drug Discovery, Life Sciences, Healthcare
About Us
Absci is a generative AI drug creation company combining AI, proprietary biological data, and high-throughput wet-lab validation to design and optimize biologic drugs. Its platform uses generative AI for de novo antibody design, target discovery, and lead optimization, with applications across challenging therapeutic targets.
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.